Ghana news briefing
Senegal produces first Africa-made generic sickle cell drug
%2Cautocrop(1200%3A630)&w=3840&q=75)
Senegal has taken a major step towards improving access to sickle cell treatment after a pharmaceutical company began locally producing DREPAF, a generic medicine based on hydroxyurea, for people living with the condition.
Senegal has begun locally manufacturing DREPAF, a generic hydroxyurea treatment for sickle cell disease, including a paediatric formulation for children from nine months.
The development is significant because sickle cell disease is particularly widespread in Africa, yet access to disease-modifying treatment remains limited.
This is a summary of the original articles listed below. Always read the source articles for the full context. GhanaSummary does not create or modify the news — we summarise and link to original publishers.
%2Cautocrop(1200%3A630)&w=3840&q=75)
